No. | CgA | Syn | CD56 | CK19 | NEC:PDCA | NEC Ki-67 | PDAC Ki-67 | NEC mitosis (10 HPF) | NEC grade |
---|
1 | + | + | NA | NA | 60%:40% | 20% | 15% | 17 | G2 |
2 | + | + | + | NA | 60%:40% | 8% | 25% | 5 | G2 |
3 | + | + | + | NA | 70%:30% | 10% | 30% | 2 | G2 |
4 | + | + | NA | NA | 70%:30% | 10% | 30% | 8 | G2 |
5 | – | + | + | + | 70%:30% | 60% | 30% | 53 | G3 |
6 | – | + | NA | + | NA | 60% | NA | NA | G3 |
- CgA Chromogranin, Syn Synaptophysin, NEC Neuroendocrine carcinoma, PDAC Pancreatic ductal adenocarcinoma, HPF High powered field, + Positive, − Negative, NA Not available. Anti-CgA (Zhongshan Goldenbridge, China). Anti-Syn (Leica, Germany). Anti-CD56 (Leica, Germany). Anti-CK19 (Dako, Denmark). Anti-Ki-67 (Zhongshan Goldenbridge, China). The sixth case was operated in other hospital and transferred to our department after liver metastasis, so the information was based on the original report